Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) Rating Reiterated at Wedbush

Analysts at Wedbush reiterated an Outperform rating on shares of Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) in a reserach note to investors, making it one of the more actively watched stocks on Wall Street. With a rating of Outperform on the stock, the company has a 52-week high of $19.46. The one-year price target of $22.75 is higher than the opening price of $18.97, that has caused a number of other analysts to issue statements on the stock recently. Stock prices sometimes get a spike to the upside when analysts reiterate coverage.

U.S. stocks closed higher Tuesday as investors anticipate the results of meetings from the Federal Reserve and the Bank of Japan.

The Dow Jones Industrial Average DJIA, +0.05% rose 9.79 points, or less than 0.1%, to close at 18,129.96.

The S&P 500 index SPX, +0.03% advanced 0.64 points to finish at 2,139.76, led by gains in the health-care and consumer-staples sectors.

The Nasdaq Composite index COMP, +0.12% gained 6.33 points, or 0.1%, to close at 5,241.35.

Yesterday Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) shares last traded at $19.24, which represents an increase of $0.33 from the previous closing price. Opening at $18.97, they varied from $18.92 and $19.37 throughout the day.

Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) currently has a market cap of 2.00B.

681,025 shares traded hands yesterday, 97 percent below normal, out of a total float 46,145,000. Trading volume is likely to increase in the next few days as momentum traders often use upticks in trading volume to determine large volume aggregation or circulation by institutional investors.

While an increase in trading for one day will not mean much, conversely, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive cue to market traders that institutions may be moving in, so institutional sponsorship is crucial.

Institutional sponsorship just refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These instituitional investors have substantial teams of analysts that research thousands of stocks. Thus, watching their interests is a good way to ensure you are buying the right stocks.

By spotting trends, moving averages allow investors to make those trends work in their favor and increase the number of winning trades.

Trades for Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX) have ranged from $7.65 – 19.46, and the stock now has a 50-day MA of $16.06 and 200-day MA of $14.20. Today’s last price is 0.01% under the 52 week high of $19.46.

Indeed, earnings growth is among the most crucial things to look at in regards to stock investing and, accordingly, investors identify companies that have grown their earnings by at least 25% for 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.